Skip to the page

Data / Form D filings / VenoStent, Inc.

VenoStent, Inc.: Form D filings

VenoStent, Inc., a health care company in Houston, TX, filed 6 Form D notices with the SEC between 2018 and 2026. The latest, on May 1, 2026, reports $10 million sold of a $10 million offering to 29 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2450 HOLCOMBE BLVD. Suite B, Houston, TX, 77021
Phone
(832) 429-5362
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1734734

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 1, 2026New notice$10,000,000$10,000,00029Apr 10, 2026sec.gov
Jul 19, 2023New notice$21,182,882$16,062,824$5,120,05860Jul 5, 2023sec.gov
Feb 16, 2021New notice$3,000,000$2,242,619$757,38124Jan 29, 2021sec.gov
Jun 10, 2020New notice$535,000$515,000$20,00016May 26, 2020sec.gov
Jul 10, 2019New notice$300,000$263,929$36,0718Jun 25, 2019sec.gov
Mar 22, 2018New notice$400,000$70,000$330,0004Mar 7, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Timothy BoireExecutive Officer, Director
Geoffrey LucksExecutive Officer, Director
Robert CrutchfieldDirector
Joel WhitleyDirector
Jim MonsorDirector

Other health care companies in Texas that filed recently

Every Form D from the week of Apr 27, 2026 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what VenoStent, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.